HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | PNC-27 |
|---|---|
| CAS number | 1159861-00-3 |
| Molecular formula | C188H293N53O44S |
| Molecular weight | 4031.7 g/mol |
| Sequence | PPLSQETFSDLWKLLKKWKMRRNQFWVKVQRG |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 10mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C (long-term -80°C), protected from light and moisture; ships on cold packs. After reconstitution, store at 2-8°C, minimize freeze-thaw cycles, and use within the validated stability window. |
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
PNC-27 is a synthetic 32-amino-acid chimeric peptide that fuses residues 12-26 of the HDM-2 (HDM2/MDM2) binding domain of human p53 to a membrane-residency / penetratin-derived leader sequence (MRP). In published research it is characterized as an anticancer tool compound that adopts an HDM-2-binding conformation, binds HDM-2 in the plasma membrane, and induces selective trans-membrane pore formation and membranolysis in cancer cells while sparing normal cells.
Documentation
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the PNC-27 reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
PNC-27 is a synthetic 32-amino-acid chimeric peptide combining a p53-derived HDM-2 binding domain (residues 12-26) with a penetratin-type membrane-residency leader. It is supplied strictly for in-vitro and laboratory research use; we do not provide medical or dosing guidance.
Every production lot includes a batch-linked COA including RP-HPLC purity, mass-spectrometry (ESI/MALDI) identity confirmation, and appearance and water-content data. COA, HPLC and MS files are available on request prior to purchase.
PNC-27 is supplied as a lyophilized powder filled into 10 ml vials. Typical purity is >=99% by HPLC target; the exact specification is confirmed on the batch COA and at RFQ.
Catalog MOQ is 50 kits (500 vials) (10 ml). We support bulk, OEM and private-label programs, including custom fill volume, labeling and packaging. Send your target volumes for a quotation.
Lyophilized PNC-27 is stored at -20°C (long-term -80°C) and shipped with cold packs. After reconstitution keep at 2-8°C, protect from light and moisture, and avoid repeated freeze-thaw cycles.
Related compounds